anonymous
Guest
anonymous
Guest
Not true. They are rare disease
So is Chemocentryx drug and that group is with Enbrel BU, so doubt they will keep Horizon rheum and neph separate.
Not true. They are rare disease
Correct. Avacopan is used by Rheumatologists...well, actually avacopan is supposed to be used by Rheums, but they don't seem to care much about it.So is Chemocentryx drug and that group is with Enbrel BU, so doubt they will keep Horizon rheum and neph separate.
So is Chemocentryx drug and that group is with Enbrel BU, so doubt they will keep Horizon rheum and neph separate.
They are KAMs and got a pay bump to KAM level when they moved to Amgen. They are lower in our range, but we have some people that came over from IBU that are really low. Their’s is rare disease drug, too. Would be weird to keep two orphan status drugs with the same targets in two different business units.no changes to Horizon alignment. All of us are staying in rare disease. Chemocentryx pay is much lower so they couldn't be aligned in rare disease without salary bumps.
So no Chemocentryx at this meeting? I thought they were "rare disease" with us? They call on some of the same offices as the GBU. Would have been good collaboration in some cases.
Because not everything is set in place yet for the changes.
Thanks Amgen, the NSM gift sucks balls!
Both men and womenLots of hotties
weird pubes
I don't agree with it but I was told Chemocentyrx was aligned with Enbrel and was staying there.
Amgen had a say in the budget for the NSM, but it was cheap. What is up with Bob? The CEO of Amgen needs pages of notes and a teleprompter to say nothing. It was funny that he had to look at Tim in the front row. Maybe he was nervous with all of that toxic male energy. Bob is a beta, for sure.
Horizon has better, higher-paid reps than Amgen. We are a round peg they will try to fit in a square space. The cultures are opposite. It was a great run. The best thing now is to wait for the money to dry up, then move on. That was the last time we would dance our asses off and drink at Tao on the company.
Amgen had a say in the budget for the NSM, but it was cheap. What is up with Bob? The CEO of Amgen needs pages of notes and a teleprompter to say nothing. It was funny that he had to look at Tim in the front row. Maybe he was nervous with all of that toxic male energy. Bob is a beta, for sure.
Horizon has better, higher-paid reps than Amgen. We are a round peg they will try to fit in a square space. The cultures are opposite. It was a great run. The best thing now is to wait for the money to dry up, then move on. That was the last time we would dance our asses off and drink at Tao on the company.
OMG yes!
The welcome gifts were lackluster at best. The food was the same just recycled EVERYDAY.
The expert booths were informative but very elementary for such a large biotech company.
Bobs speech was odd and yes completely read off the page.
Culture is COMPLETELY DIFFERENT! Last year I left NSM inspired, this year I left it uninspired.
While P club in Monaco looks fun, the whole RSUs part is NBD, I’d rather have $.
I just don’t get the feeling that Amgen cares like Horizon did. We’re just numbers and everything is paired down to save money for shareholders.
Great meeting and we all are pumped to be at Amgen. I couldn’t understand why Timmy was there. I guess for free food and drinks.